Technologies
Risk-Takers Will Like Citius Oncology Inc (NASDAQ: CTOR).
In the last trading session, 92319.0 shares of the Citius Oncology Inc (NASDAQ:CTOR) were traded, and its beta was -0.70. Most recently the company’s share
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
